Mediclinic share price surges as board rates latest Remgro offer Consortium made its fourth proposal that values the group at $4.44 billion
AFTER rejecting three offers, Mediclinic International’s board said yesterday a fourth offer that values the private hospital group at $4.44 billion (R74.1bn), by the Remgro and Mediterranean Shipping Company (MSC), consortium appears attractive to shareholders. The consortium made an unsoli- cited cash offer to acquire all of Mediclinic on May 26. On June 9, it’s board rejected the offer of 463 pence (R92.20) a share (including a final dividend of 3p paper share for the year to March 31), on the basis that it significantly undervalued Mediclinic. Remgro is Mediclinic’s majority 44.6 percent shareholder. Mediclinic’s share price shot up 8.6 percent to R95 on the JSE yesterday afternoon, while the price was up 7.46 percent to 475.20p per share on the London Stock Exchange. Its…